Tamer Elbayoumi

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody

Anatoly N. Lukyanov, Tamer Elbayoumi, Ananthsrinivas Chakilam et al. · Journal of Controlled Release · 2004 · 293 citations

Pharmacy, Molecular Pharmaceutics, Oncology +16

Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy <i>In vivo</i> of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody

Tamer Elbayoumi, Vladimir P. Torchilin · Clinical Cancer Research · 2009 · 168 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Mixed micelles made of poly(ethylene glycol)–phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin

Tamer Elbayoumi, Vladimir P. Torchilin · International Journal of Pharmaceutics · 2005 · 160 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Current Trends in Liposome Research

Tamer Elbayoumi, Vladimir P. Torchilin · Methods in molecular biology · 2009 · 132 citations

Pharmacy, Biochemistry, Drug Delivery +13

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines

Tamer Elbayoumi, Vladimir P. Torchilin · European Journal of Pharmaceutical Sciences · 2007 · 107 citations · Full text

Pharmacy, Oncology, Pharmacology +14